Ligand validation:8GVM

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 8GVM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8GVM_CDL_C_305	13%	22%	0.253	0.811	1.48	1.73	14	22	17	0	89%	1
8GVM_CDL_P_304	6%	23%	0.288	0.766	1.48	1.68	10	13	13	0	80%	1
8GVM_CDL_N_601	3%	34%	0.35	0.702	1.43	1.19	12	11	13	0	96%	1
8GVM_CDL_T_102	2%	28%	0.327	0.626	1.4	1.48	12	13	15	0	97%	1
9IKG_CDL_L_101	53%	71%	0.147	0.919	0.41	0.7	-	4	4	0	94%	1
9KUM_CDL_L_101	52%	72%	0.144	0.913	0.45	0.63	-	2	6	0	94%	1
9IKF_CDL_L_101	51%	72%	0.152	0.916	0.39	0.69	-	2	3	0	94%	1
9KUL_CDL_L_101	50%	73%	0.154	0.916	0.42	0.62	-	2	10	0	94%	1
9KUK_CDL_L_101	49%	74%	0.153	0.911	0.4	0.6	-	2	7	0	94%	1
9GCX_CDL_C_504	62%	68%	0.143	0.934	0.43	0.79	-	2	16	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.